{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:05:44Z","timestamp":1789005944586,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014160","name":"Regional Health Agency Hauts-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017007","name":"Agence R\u00e9gionale de Sant\u00e9 \u00cele-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017007","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eclinm.2025.103577","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:13:30Z","timestamp":1760660010000},"page":"103577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Oral anticoagulant reversal and mortality in trauma patients: a multicentre propensity score\u2013matched cohort study"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-9242","authenticated-orcid":false,"given":"Elodie","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1845-8610","authenticated-orcid":false,"given":"Jean-Luc","family":"Hanouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Vardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Hericher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Audibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Huet-Garrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paer-S\u00e9lim","family":"Abback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2854-0909","authenticated-orcid":false,"given":"Benjamin","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-2104","authenticated-orcid":false,"given":"Olivier","family":"Duranteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-599X","authenticated-orcid":false,"given":"Pierre-Antoine","family":"Allain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Botrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1439-9347","authenticated-orcid":false,"given":"Jean","family":"Pasqueron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Godier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103577_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition","volume":"27","author":"Rossaint","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.eclinm.2025.103577_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.injury.2010.11.003","article-title":"Early coagulopathy in trauma patients: an on-scene and hospital admission study","volume":"43","author":"Floccard","year":"2012","journal-title":"Injury"},{"key":"10.1016\/j.eclinm.2025.103577_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/TA.0000000000000314","article-title":"Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients","volume":"77","author":"Deras","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.eclinm.2025.103577_bib4","first-page":"16","article-title":"Trauma-induced coagulopathy: overview of an emerging medical problem from pathophysiology to outcomes","volume":"8","author":"Savioli","year":"2021","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.eclinm.2025.103577_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/EJA.0000000000001803","article-title":"Management of severe peri-operative bleeding: guidelines from the European Society of Anaesthesiology and Intensive Care: second update 2022","volume":"40","author":"Kietaibl","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.eclinm.2025.103577_bib6","first-page":"101584","volume":"44","author":"Douillet","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.eclinm.2025.103577_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/TA.0000000000001340","article-title":"Management of anticoagulation with rivaroxaban in trauma and acute care surgery: complications and reversal strategies as compared to warfarin therapy","volume":"82","author":"Myers","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.eclinm.2025.103577_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/phar.2901","article-title":"Is reversal of anticoagulants necessary in neurologically intact traumatic intracranial hemorrhage?","volume":"44","author":"Powell","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eclinm.2025.103577_bib9","article-title":"Management of factor Xa inhibitor-related traumatic non-intracranial bleeding events with andexanet alfa or four-factor prothrombin complex concentrate in a US multicenter observational study","volume":"5","author":"Dobesh","year":"2024","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.eclinm.2025.103577_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.eclinm.2025.103577_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13054-018-2026-9","article-title":"Development and validation of a pre-hospital \u2018Red Flag\u2019 alert for activation of intra-hospital haemorrhage control response in blunt trauma","volume":"22","author":"Hamada","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.eclinm.2025.103577_bib12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/TA.0000000000001189","article-title":"Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin","volume":"81","author":"Maung","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.eclinm.2025.103577_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajem.2016.10.002","article-title":"The impact of preinjury antithrombotic medication on hemostatic interventions in trauma patients","volume":"35","author":"Kudo","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.eclinm.2025.103577_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/TA.0000000000002823","article-title":"Comparison of direct oral anticoagulant and vitamin K antagonists on outcomes among elderly and nonelderly trauma patients","volume":"89","author":"Nishimura","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.eclinm.2025.103577_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0003134820934419","article-title":"The impact of anticoagulation on trauma outcomes: an national trauma Data bank Study","volume":"86","author":"Nguyen","year":"2020","journal-title":"Am Surg"},{"key":"10.1016\/j.eclinm.2025.103577_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00091-2","article-title":"The effects of antithrombotic therapy on head trauma and its management","volume":"11","author":"Koiso","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2025.103577_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94675-7","article-title":"Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients","volume":"11","author":"Bl\u00e4sius","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2025.103577_bib18","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.injury.2020.07.063","article-title":"Comparison of outcomes in non-head injured trauma patients using pre-injury warfarin or direct oral anticoagulant therapy","volume":"51","author":"van Erp","year":"2020","journal-title":"Injury"},{"key":"10.1016\/j.eclinm.2025.103577_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.injury.2016.08.016","article-title":"Direct oral anticoagulants compared with warfarin in patients with severe blunt trauma","volume":"48","author":"Feeney","year":"2017","journal-title":"Injury"},{"key":"10.1016\/j.eclinm.2025.103577_bib20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/TA.0000000000001245","article-title":"Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: a TQIP study","volume":"81","author":"Feeney","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.eclinm.2025.103577_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00068-020-01429-7","article-title":"Mortality in relation to presence and type of oral antithrombotic agent among adult trauma patients: a single-center retrospective cohort study","volume":"48","author":"Yuval","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1016\/j.eclinm.2025.103577_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.surg.2019.04.039","article-title":"Association of mortality among trauma patients taking preinjury direct oral anticoagulants versus vitamin K antagonists","volume":"166","author":"LaDuke","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.eclinm.2025.103577_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clineuro.2015.05.035","article-title":"Rivaroxaban and intracranial haemorrhage after mild traumatic brain injury: a dangerous combination?","volume":"136","author":"Beynon","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.eclinm.2025.103577_bib24","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2023.7.FOCUS23380","article-title":"Impact of premorbid oral anticoagulant use on survival in patients with traumatic intracranial hemorrhage","volume":"55","author":"Botros","year":"2023","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.eclinm.2025.103577_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.annfar.2013.04.016","article-title":"[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - march 2013]","volume":"32","author":"Pernod","year":"2013","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.eclinm.2025.103577_bib26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2025.103577_bib31","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/cc13843","article-title":"Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)","volume":"18","author":"Tazarourte","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.eclinm.2025.103577_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.thromres.2020.11.011","article-title":"Correction of international normalised ratio in major bleeding related to vitamin K antagonists is associated with better survival: a UK study","volume":"197","author":"Tan","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.eclinm.2025.103577_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40256-019-00360-6","article-title":"Real world outcomes associated with idarucizumab: population-based retrospective cohort study","volume":"20","author":"Singh","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.eclinm.2025.103577_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103577_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.121.057844","article-title":"Final Study report of andexanet alfa for major bleeding with factor Xa inhibitors","volume":"147","author":"Milling","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2025.103577_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2025.103577_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","article-title":"Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage","volume":"390","author":"Connolly","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103577_bib34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2023.4080","article-title":"Efficacy and safety of early administration of 4-Factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: the PROCOAG randomized clinical trial","volume":"329","author":"Bouzat","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2025.103577_bib35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1055\/a-1400-6159","article-title":"Restart of anticoagulant therapy and risk of thrombosis, rebleeding, and death after factor Xa inhibitor reversal in major bleeding patients","volume":"121","author":"Milling","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.eclinm.2025.103577_bib36","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/bloodadvances.2022009015","article-title":"INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma","volume":"7","author":"Hood","year":"2023","journal-title":"Blood Adv"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:34:29Z","timestamp":1769060069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025005103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"alternative-id":["S2589537025005103"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103577","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral anticoagulant reversal and mortality in trauma patients: a multicentre propensity score\u2013matched cohort study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103577"}}